Single-Dose Cefixime Versus Single-Dose Ceftriaxone in the Treatment of Antimicrobial-Resistant Neisseria Gonorrhoeae Infection

Journal of Infectious Diseases - United Kingdom
doi 10.1093/infdis/166.4.919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

A Phase 1 Pharmacokinetic and Safety Study of Extended Duration, High-Dose Cefixime for Cephalosporin-Resistant Neisseria Gonorrhoeae in the Pharynx

Sexually Transmitted Diseases
Public HealthMicrobiologyEnvironmentalDermatologyInfectious DiseasesOccupational Health
2018English

Single-Dose Pharmacokinetics of Ceftriaxone in Healthy Chinese Adults.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Single-Dose Pharmacokinetics of Ceftriaxone in Infants and Young Children.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

Neisseria Gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada

JAMA - Journal of the American Medical Association
Medicine
2013English

Single-Dose Treatment of Gonorrhœa

The Lancet
Medicine
1972English

Neisseria gonorrhoeaeResistant to Ceftriaxone and Cefixime, Argentina

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2016English

Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria Gonorrhoeae Strain, Alberta, Canada, 2018

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2019English

Comparison of Single-Dose Cefuroxime Axetil With Ciprofloxacin in Treatment of Uncomplicated Gonorrhea Caused by Penicillinase-Producing and Non-Penicillinase-Producing Neisseria Gonorrhoeae Strains.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

Multidrug-Resistant Neisseria Gonorrhoeae

CMAJ
Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy